Systemic inflammation in early neonatal mice induces transient and lasting neurodegenerative effects

Journal of Neuroinflammation

Volumn 12, Issue 1, 2015, Pages

  Cardoso, Filipa L ^a   Herz, Jasmin ^b   Fernandes, Adelaide ^a   Rocha, João ^a   Sepodes, Bruno ^a   Brito, Maria A ^a   McGavern, Dorian B ^b   Brites, Dora ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Astrocytes; Autotaxin; HMGB1; LPS; Microglia; Myelination; Neurodevelopment; Neurons

Indexed keywords

AUTOTAXIN; CHEMOKINE RECEPTOR CX3CR1; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; 4-HYDROXY-ANETHOLE TRITHIONE; ANETHOLE TRITHIONE; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN; MBP PROTEIN, MOUSE; MYELIN BASIC PROTEIN; TLR4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BONE MARROW CELL; BRAIN NERVE CELL; BRAIN WEIGHT; CELL LOSS; CELL MIGRATION; CELL PROLIFERATION; CEREBELLUM HYPOPLASIA; CONTROLLED STUDY; INFLAMMATION; MICROGLIA; MOUSE; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEURAL STEM CELL; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PHAGOCYTOSIS; PONS; WEIGHT REDUCTION; WHITE MATTER; ABNORMALITIES; AGE; ANALOGS AND DERIVATIVES; ANIMAL; BODY WEIGHT; C57BL MOUSE; CEREBELLUM; CHEMICALLY INDUCED; COMPLICATION; DEMYELINATING DISEASE; DEVELOPMENTAL DISABILITIES; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NERVOUS SYSTEM MALFORMATIONS; NEURODEGENERATIVE DISEASES; PATHOLOGY; TIME FACTOR; TRANSGENIC MOUSE;

AGE FACTORS; ANETHOLE TRITHIONE; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CEREBELLUM; DEMYELINATING DISEASES; DEVELOPMENTAL DISABILITIES; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HMGB1 PROTEIN; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MYELIN BASIC PROTEIN; NERVOUS SYSTEM MALFORMATIONS; NEURODEGENERATIVE DISEASES; RECEPTORS, CHEMOKINE; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 84929431467     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-015-0299-3     Document Type: Article

References (117)

1. Martin GS. Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 2012;10(6):701-6.doi:101586/eri.12.50.
2. Ogunlesi TA, Ogunfowora OB. Predictors of mortality in neonatal septicemia in an underresourced setting. J Natl Med Assoc. 2010;102(10):915-21.
3. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375(9730):1969-87.doi:101016/S0140-6736(10)60549-1.
4. Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015;61(1):1-13.doi:101093/tropej/fmu079.
5. Mukherjee R, McQuinn TC, Dugan MA, Saul JP, Spinale FG. Cardiac function and circulating cytokines after endotoxin exposure in neonatal mice. Pediatr Res. 2010;68(5):381-6.doi:101203/PDR.0b013e3181efbe10.
6. Brochu ME, Girard S, Lavoie K, Sebire G. Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: an experimental study. J Neuroinflammation. 2011;8:55.doi:101186/1742-2094-8-55.
7. Brites D, Fernandes A. Bilirubin-induced neural impairment: a special focus on myelination, age-related windows of susceptibility and associated co-morbidities. Semin Fetal Neonatal Med. 2015;20(1):14-9.doi:101016/j.siny.2014.12.002.
8. Ming Z, Sawicki G, Bekar LK. Acute systemic LPS-mediated inflammation induces lasting changes in mouse cortical neuromodulation and behavior. Neurosci Lett. 2015;590C:96-100.doi:101016/j.neulet.2015.01.081.
9. Anderson ST, Commins S, Moynagh PN, Coogan AN. Lipopolysaccharide-induced sepsis induces long-lasting affective changes in the mouse. Brain Behav Immun. 2015;43:98-109.doi:101016/j.bbi.2014.07.007.
10. Dinel AL, Joffre C, Trifilieff P, Aubert A, Foury A, Le Ruyet P, et al. Inflammation early in life is a vulnerability factor for emotional behavior at adolescence and for lipopolysaccharide-induced spatial memory and neurogenesis alteration at adulthood. J Neuroinflammation. 2014;11(1):155.doi:101186/s12974-014-0155-x.
11. Rousset CI, Kassem J, Aubert A, Planchenault D, Gressens P, Chalon S, et al. Maternal exposure to lipopolysaccharide leads to transient motor dysfunction in neonatal rats. Dev Neurosci. 2013;35(2-3):172-81.doi:101159/000346579.
12. Osuchowski MF, Welch K, Yang H, Siddiqui J, Remick DG. Chronic sepsis mortality characterized by an individualized inflammatory response. J Immunol. 2007;179(1):623-30.doi:101016/0022-4804(80)90037-2.
13. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res. 1980;29(2):189-201. doi:0022-4804(80)90037-2.
14. Nemzek JA, Hugunin KM, Opp MR. Modeling sepsis in the laboratory: merging sound science with animal well-being. Comp Med. 2008;58(2):120-8.
15. Breuillé D, Farge MC, Rose F, Arnal M, Attaix D, Obled C. Pentoxifylline decreases body weight loss and muscle protein wasting characteristics of sepsis. Am J Physiol. 1993;265(4 Pt 1):E660-6.
16. Kinney JM, Gump FE, Long CL. Energy and tissue fuel in human injury and sepsis. Adv Exp Med Biol. 1972;33:401-7.doi:101007/978-1-4684-3228-2_41.
17. Rousset CI, Chalon S, Cantagrel S, Bodard S, Andres C, Gressens P, et al. Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats. Pediatr Res. 2006;59(3):428-33.doi:101203/01.pdr.0000199905.08848.55.
18. Hermansen MC, Hermansen MG. Perinatal infections and cerebral palsy. Clin Perinatol. 2006;33(2):315-33.doi:101016/j.clp.2006.03.002.
19. Lazosky A, Young GB, Zirul S, Phillips R. Quality of life after septic illness. J Crit Care. 2010;25(3):406-12.doi:101016/j.jcrc.2009.10.001.
20. Puntener U, Booth SG, Perry VH, Teeling JL. Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia. J Neuroinflammation. 2012;9:146.doi:101186/1742-2094-9-146.
21. Wang X, Hellgren G, Lofqvist C, Li W, Hellstrom A, Hagberg H, et al. White matter damage after chronic subclinical inflammation in newborn mice. J Child Neurol. 2009;24(9):1171-8.doi:101177/0883073809338068.
22. Banks WA, Robinson SM. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav Immun. 2010;24(1):102-9.doi:101016/j.bbi.2009.09.001.
23. Jeong HK, Jou I, Joe EH. Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. Exp Mol Med. 2010;42(12):823-32.doi:103858/emm.2010.42.12.085.
24. Bodea LG, Wang Y, Linnartz-Gerlach B, Kopatz J, Sinkkonen L, Musgrove R, et al. Neurodegeneration by activation of the microglial complement-phagosome pathway. J Neurosci. 2014;34(25):8546-56.doi:101523/JNEUROSCI.5002-13.2014.
25. Banks WA, Erickson MA. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis. 2010;37(1):26-32.doi:101016/j.nbd.2009.07.031.
26. Grab DJ, Chakravorty SJ, van der Heyde H, Stins MF. How can microbial interactions with the blood-brain barrier modulate astroglial and neuronal function? Cell Microbiol. 2011;13(10):1470-8.doi:101111/j.1462-5822.2011.01661.x.
27. Cardoso FL, Brites D, Brito MA. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev. 2010;64(2):328-63.doi:101016/j.brainresrev.2010.05.003.
28. Nayak D, Roth TL, McGavern DB. Microglia development and function. Annu Rev Immunol. 2014;32:367-402.doi:101146/annurev-immunol-032713-120240.
29. Cardoso FL, Kittel A, Veszelka S, Palmela I, Toth A, Brites D, et al. Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells. PLoS One. 2012;7(5):e35919.doi:101371/journal.pone.0035919.
30. Dohgu S, Fleegal-DeMotta MA, Banks WA. Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF. J Neuroinflammation. 2011;8:167.doi:101186/1742-2094-8-167.
31. Sá-Pereira I, Brites D, Brito MA. Neurovascular unit: a focus on pericytes. Mol Neurobiol. 2012;45(2):327-47.doi:101007/s12035-012-8244-2.
32. Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan Jr DJ. Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood. 2009;114(19):4243-52.doi:101182/blood-2009-06-226415.
33. Brites D, Bhutani VK. Pathways involving bilirubin and other brain-injuring agents. In: Dan B, Mayston M, Paneth NLR, editors. Cerebral Palsy: Science and Clinical Practice. London: Mac Keith Press; 2014. p. 131-50.
34. Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. 2010;468(7323):562-6.doi:101038/nature09513.
35. Falcão AS, Fernandes A, Brito MA, Silva RFM, Brites D. Bilirubin-induced inflammatory response, glutamate release, and cell death in rat cortical astrocytes are enhanced in younger cells. Neurobiol Dis. 2005;20(2):199-206.doi:101016/j.nbd.2005.03.001.
36. Falcão AS, Silva RFM, Vaz AR, Gomes C, Fernandes A, Barateiro A, et al. Cross-talk between neurons and astrocytes in response to bilirubin: adverse secondary impacts. Neurotox Res. 2014;26(1):1-15.doi:101007/s12640-013-9427-y.
37. Lamar CD, Hurley RA, Taber KH. Sepsis-associated encephalopathy: review of the neuropsychiatric manifestations and cognitive outcome. J Neuropsychiatry Clin Neurosci. 2011;23(3):237-41.doi:101176/appi.neuropsych.23.3.237.
38. Awada R, Rondeau P, Gres S, Saulnier-Blache JS, Lefebvre d'Hellencourt C, Bourdon E. Autotaxin protects microglial cells against oxidative stress. Free Radic Biol Med. 2012;52(2):516-26.doi:101016/j.freeradbiomed.2011.11.014.
39. Nimmervoll B, White R, Yang JW, An S, Henn C, Sun JJ, et al. LPS-induced microglial secretion of TNFalpha increases activity-dependent neuronal apoptosis in the neonatal cerebral cortex. Cereb Cortex. 2013;23(7):1742-55.doi:101093/cercor/bhs156.
40. Harry GJ, Kraft AD. Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology. 2012;33(2):191-206.doi:101016/j.neuro.2012.01.012.
41. Torres-Platas SG, Comeau S, Rachalski A, Bo GD, Cruceanu C, Turecki G, et al. Morphometric characterization of microglial phenotypes in human cerebral cortex. J Neuroinflammation. 2014;11:12.doi:101186/1742-2094-11-12.
42. Albert J, Radomski A, Soop A, Sollevi A, Frostell C, Radomski MW. Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol Scand. 2003;47(4):407-10.doi:101034/j.1399-6576.2003.00059.x.
43. Xiao H, Siddiqui J, Remick DG. Mechanisms of mortality in early and late sepsis. Infect Immun. 2006;74(9):5227-35.doi:101128/IAI.01220-05.
44. Fu HQ, Yang T, Xiao W, Fan L, Wu Y, Terrando N, et al. Prolonged neuroinflammation after lipopolysaccharide exposure in aged rats. PLoS One. 2014;9(8):e106331.doi:101371/journal.pone.0106331.
45. Starr ME, Ueda J, Takahashi H, Weiler H, Esmon CT, Evers BM, et al. Age-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin. Blood. 2010;115(23):4886-93.doi:101182/blood-2009-10-246678.
46. Mao K, Chen S, Chen M, Ma Y, Wang Y, Huang B, et al. Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. Cell Res. 2013;23(2):201-12.doi:101038/cr.2013.6.
47. Wang X, Stridh L, Li W, Dean J, Elmgren A, Gan L, et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol. 2009;183(11):7471-7.doi:104049/jimmunol.0900762.
48. Nayak D, Zinselmeyer BH, Corps KN, McGavern DB. In vivo dynamics of innate immune sentinels in the CNS. Intravital. 2012;1(2):95-106.doi:104161/intv.22823.
49. Huang D, Shi FD, Jung S, Pien GC, Wang J, Salazar-Mather TP, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. Faseb J. 2006;20(7):896-905.doi:101096/fj.05-5465com.
50. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol. 2000;20(11):4106-14.
51. Jin L, Li J, Nation RL, Nicolazzo JA. Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice. Antimicrob Agents Chemother. 2011;55(2):502-7.doi:101128/AAC.01273-10.
52. Erickson MA, Hartvigson PE, Morofuji Y, Owen JB, Butterfield DA, Banks WA. Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J Neuroinflammation. 2012;9:150.doi:101186/1742-2094-9-150.
53. Ratilal BO, Arroja MM, Rocha JP, Fernandes AM, Barateiro AP, Brites DM, et al. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion. J Neurosurg. 2014;121(1):55-62.doi:103171/2014.2.JNS132197.
54. Morrison HW, Filosa JA. A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. J Neuroinflammation. 2013;10:4.doi:101186/1742-2094-10-4.
55. Walker AK, Budac DP, Bisulco S, Lee AW, Smith RA, Beenders B, et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6 J mice. Neuropsychopharmacology. 2013;38(9):1609-16.doi:101038/npp.2013.71.
56. Lawson MA, McCusker RH, Kelley KW. Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. J Neuroinflammation. 2013;10:54.doi:101186/1742-2094-10-54.
57. Baizer JS. Unique features of the human brainstem and cerebellum. Front Hum Neurosci. 2014;8:202.doi:103389/fnhum.2014.00202.
58. Kesner RP. Behavioral functions of the CA3 subregion of the hippocampus. Learn Mem. 2007;14(11):771-81.doi:101101/lm.688207.
59. Kullmann JA, Neumeyer A, Wickertsheim I, Bottcher RT, Costell M, Deitmer JW, et al. Purkinje cell loss and motor coordination defects in profilin1 mutant mice. Neuroscience. 2012;223:355-64.doi:101016/j.neuroscience.2012.07.055.
60. Mallard C, Wang X. Infection-induced vulnerability of perinatal brain injury. Neurol Res Int. 2012;2012:102153.doi:101155/2012/102153.
61. Tissieres P, Ochoda A, Dunn-Siegrist I, Drifte G, Morales M, Pfister R, et al. Innate immune deficiency of extremely premature neonates can be reversed by interferon-gamma. PLoS One. 2012;7(3):e32863.doi:101371/journal.pone.0032863.
62. Leviton A, Gressens P. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci. 2007;30(9):473-8.doi:101016/j.tins.2007.05.009.
63. Schlapbach LJ, Aebischer M, Adams M, Natalucci G, Bonhoeffer J, Latzin P, et al. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics. 2011;128(2):e348-57.doi:101542/peds.2010-3338.
64. Mitha A, Foix-L'Helias L, Arnaud C, Marret S, Vieux R, Aujard Y, et al. Neonatal infection and 5-year neurodevelopmental outcome of very preterm infants. Pediatrics. 2013;132(2):E372-E80. doi:DOI 10.1542/peds.2012-3979.
65. Hentges CR, Silveira RC, Procianoy RS, Carvalho CG, Filipouski GR, Fuentefria RN, et al. Association of late-onset neonatal sepsis with late neurodevelopment in the first two years of life of preterm infants with very low birth weight. J Pediatr (Rio J). 2014;90(1):50-7.doi:101016/j.jped.2013.10.002.
66. Strunk T, Inder T, Wang X, Burgner D, Mallard C, Levy O. Infection-induced inflammation and cerebral injury in preterm infants. Lancet Infect Dis. 2014;14(8):751-62.doi:101016/S1473-3099(14)70710-8.
67. Kidokoro H, Neil JJ, Inder TE. New MR imaging assessment tool to define brain abnormalities in very preterm infants at term. AJNR Am J Neuroradiol. 2013;34(11):2208-14.doi:103174/ajnr.A3521.
68. Alshaikh B, Yusuf K, Sauve R. Neurodevelopmental outcomes of very low birth weight infants with neonatal sepsis: systematic review and meta-analysis. J Perinatol. 2013;33(7):558-64.doi:101038/jp.2012.167.
69. Cunningham C. Microglia and neurodegeneration: the role of systemic inflammation. Glia. 2013;61(1):71-90.doi:101002/glia.22350.
70. Smith PL, Hagberg H, Naylor AS, Mallard C. Neonatal peripheral immune challenge activates microglia and inhibits neurogenesis in the developing murine hippocampus. Dev Neurosci. 2014;36(2):119-31.doi:101159/000359950.
71. Lin HY, Huang CC, Chang KF. Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat. Pediatr Res. 2009;66(3):254-9.doi:101203/PDR.0b013e3181b0d336.
72. Ikeda T, Yang L, Ikenoue T, Mallard C, Hagberg H. Endotoxin-induced hypoxic-ischemic tolerance is mediated by up-regulation of corticosterone in neonatal rat. Pediatr Res. 2006;59(1):56-60.doi:101203/01.pdr.0000191140.87314.ce.
73. Thomas RC, Bath MF, Stover CM, Lambert DG, Thompson JP. Exploring LPS-induced sepsis in rats and mice as a model to study potential protective effects of the nociceptin/orphanin FQ system. Peptides. 2014;61:56-60.doi:101016/j.peptides.2014.08.009.
74. Nguyen MD, D'Aigle T, Gowing G, Julien JP, Rivest S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2004;24(6):1340-9.doi:101523/JNEUROSCI.4786-03.2004.
75. Erickson MA, Banks WA. Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav Immun. 2011;25(8):1637-48.doi:101016/j.bbi.2011.06.006.
76. Du X, Fleiss B, Li H, D'Angelo B, Sun Y, Zhu C, et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS One. 2011;6(5):e19583.doi:101371/journal.pone.0019583.
77. Fan LW, Kaizaki A, Tien LT, Pang Y, Tanaka S, Numazawa S, et al. Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats. Neuroscience. 2013;240:27-38.doi:101016/j.neuroscience.2013.02.041.
78. Wang X, Hagberg H, Zhu C, Jacobsson B, Mallard C. Effects of intrauterine inflammation on the developing mouse brain. Brain Res. 2007;1144:180-5.doi:101016/j.brainres.2007.01.083.
79. Graf AE, Haines KM, Pierson CR, Bolon BN, Houston RH, Velten M, et al. Perinatal inflammation results in decreased oligodendrocyte numbers in adulthood. Life Sci. 2014;94(2):164-71.doi:101016/j.lfs.2013.11.015.
80. Järlestedt K, Naylor AS, Dean J, Hagberg H, Mallard C. Decreased survival of newborn neurons in the dorsal hippocampus after neonatal LPS exposure in mice. Neuroscience. 2013;253:21-8.doi:101016/j.neuroscience.2013.08.040.
81. Chung DW, Yoo KY, Hwang IK, Kim DW, Chung JY, Lee CH, et al. Systemic administration of lipopolysaccharide induces cyclooxygenase-2 immunoreactivity in endothelium and increases microglia in the mouse hippocampus. Cell Mol Neurobiol. 2010;30(4):531-41.doi:101007/s10571-009-9477-0.
82. Zhao J, Kim KD, Yang X, Auh S, Fu YX, Tang H. Hyper innate responses in neonates lead to increased morbidity and mortality after infection. Proc Natl Acad Sci U S A. 2008;105(21):7528-33.doi:101073/pnas.0800152105.
83. Girard S, Sebire H, Brochu ME, Briota S, Sarret P, Sebire G. Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries. Brain Behav Immun. 2012;26(8):1331-9.doi:101016/j.bbi.2012.09.001.
84. Dilek M, Kumral A, Okyay E, Ozbal S, Tugyan K, Tuzun F, et al. Protective effects of pentoxifylline on lipopolysaccharide-induced white matter injury in a rat model of periventricular leukomalasia. J Matern Fetal Neonatal Med. 2013;26(18):1865-71.doi:103109/14767058.2013.798290.
85. Pang Y, Fan LW, Zheng B, Campbell LR, Cai Z, Rhodes PG. Dexamethasone and betamethasone protect against lipopolysaccharide-induced brain damage in neonatal rats. Pediatr Res. 2012;71(5):552-8.doi:101038/pr.2012.9.
86. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463-516.doi:101146/annurev.cellbio.17.1.463.
87. Milner R. Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin. Glia. 2009;57(7):714-23.doi:101002/glia.20799.
88. Tilling T, Korte D, Hoheisel D, Galla HJ. Basement membrane proteins influence brain capillary endothelial barrier function in vitro. J Neurochem. 1998;71(3):1151-7.
89. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke. 1998;29(10):2189-95.
90. Aid S, Silva AC, Candelario-Jalil E, Choi SH, Rosenberg GA, Bosetti F. Cyclooxygenase-1 and -2 differentially modulate lipopolysaccharide-induced blood-brain barrier disruption through matrix metalloproteinase activity. J Cereb Blood Flow Metab. 2010;30(2):370-80.doi:101038/jcbfm.2009.223.
91. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4. J Exp Med. 1999;189(11):1777-82.
92. Qiu J, Xu J, Zheng Y, Wei Y, Zhu X, Lo EH, et al. High-mobility group box 1 promotes metalloproteinase-9 upregulation through toll-like receptor 4 after cerebral ischemia. Stroke. 2010;41(9):2077-82.doi:101161/STROKEAHA.110.590463.
93. Caldeira C, Oliveira AF, Cunha C, Vaz AR, Falcão AS, Fernandes A, et al. Microglia change from a reactive to an age-like phenotype with the time in culture. Front Cell Neurosci. 2014;8:152.doi:103389/fncel.2014.00152.
94. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139-62.doi:101146/annurev-immunol-030409-101323.
95. Goto T, Hussein MH, Kato S, Daoud GA, Kato T, Kakita H, et al. Endothelin receptor antagonist attenuates inflammatory response and prolongs the survival time in a neonatal sepsis model. Intensive Care Med. 2010;36(12):2132-9.doi:101007/s00134-010-2040-0.
96. Kato S, Hussein MH, Kakita H, Goto T, Daoud GA, Kato T, et al. Edaravone, a novel free radical scavenger, reduces high-mobility group box 1 and prolongs survival in a neonatal sepsis model. Shock. 2009;32(6):586-92.doi:101097/SHK.0b013e3181a2b886.
97. Agnello D, Wang H, Yang H, Tracey KJ, Ghezzi P. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine. 2002;18(4):231-6.doi:101006/cyto.2002.0890.
98. Sevastou I, Kaffe E, Mouratis MA, Aidinis V. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes. Biochim Biophys Acta. 2013;1831(1):42-60.doi:101016/j.bbalip.2012.07.019.
99. Awada R, Saulnier-Blache JS, Gres S, Bourdon E, Rondeau P, Parimisetty A, et al. Autotaxin downregulates LPS-induced microglia activation and pro-inflammatory cytokines production. J Cell Biochem. 2014;115(12):2123-32.doi:101002/jcb.24889.
100. Granger JI, Ratti PL, Datta SC, Raymond RM, Opp MR. Sepsis-induced morbidity in mice: effects on body temperature, body weight, cage activity, social behavior and cytokines in brain. Psychoneuroendocrinology. 2013;38(7):1047-57.doi:101016/j.psyneuen.2012.10.010.
101. Nishioku T, Dohgu S, Takata F, Eto T, Ishikawa N, Kodama KB, et al. Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice. Cell Mol Neurobiol. 2009;29(3):309-16.doi:101007/s10571-008-9322-x.
102. Bland ST, Beckley JT, Young S, Tsang V, Watkins LR, Maier SF, et al. Enduring consequences of early-life infection on glial and neural cell genesis within cognitive regions of the brain. Brain Behav Immun. 2010;24(3):329-38.doi:101016/j.bbi.2009.09.012.
103. Gomez-Nicola D, Valle-Argos B, Pita-Thomas DW, Nieto-Sampedro M. Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury. Glia. 2008;56(5):494-505.doi:101002/glia.20628.
104. Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell. 2005;120(3):421-33.doi:101016/j.cell.2004.12.020.
105. Miyamoto A, Wake H, Moorhouse AJ, Nabekura J. Microglia and synapse interactions: fine tuning neural circuits and candidate molecules. Front Cell Neurosci. 2013;7:70.doi:103389/fncel.2013.00070.
106. Pang Y, Fan LW, Tien LT, Dai X, Zheng B, Cai Z, et al. Differential roles of astrocyte and microglia in supporting oligodendrocyte development and myelination in vitro. Brain Behav. 2013;3(5):503-14.doi:101002/brb3.152.
107. Lutz SE, Zhao Y, Gulinello M, Lee SC, Raine CS, Brosnan CF. Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci. 2009;29(24):7743-52.doi:101523/JNEUROSCI.0341-09.2009.
108. van den Heuij LG, Mathai S, Davidson JO, Lear CA, Booth LC, Fraser M, et al. Synergistic white matter protection with acute-on-chronic endotoxin and subsequent asphyxia in preterm fetal sheep. J Neuroinflammation. 2014;11:89.doi:101186/1742-2094-11-89.
109. Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, Pagani F, et al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat Neurosci. 2014;17(3):400-6.doi:101038/nn.3641.
110. Favrais G, van de Looij Y, Fleiss B, Ramanantsoa N, Bonnin P, Stoltenburg-Didinger G, et al. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol. 2011;70(4):550-65.doi:101002/ana.22489.
111. Volpe JJ. Systemic inflammation, oligodendroglial maturation, and the encephalopathy of prematurity. Ann Neurol. 2011;70(4):525-9.doi:101002/ana.22533.
112. Fleiss B, Gressens P. Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? Lancet Neurol. 2012;11(6):556-66.doi:101016/S1474-4422(12)70058-3.
113. Sherwin C, Fern R. Acute lipopolysaccharide-mediated injury in neonatal white matter glia: role of TNF-alpha, IL-1beta, and calcium. J Immunol. 2005;175(1):155-61.doi:104049/jimmunol.175.1.155.
114. Kaya M, Palanduz A, Kalayci R, Kemikler G, Simsek G, Bilgic B, et al. Effects of lipopolysaccharide on the radiation-induced changes in the blood-brain barrier and the astrocytes. Brain Res. 2004;1019(1-2):105-12.doi:101016/j.brainres.2004.05.102.
115. Hulshof S, van Haastert ES, Kuipers HF, van den Elsen PJ, De Groot CJ, van der Valk P, et al. CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J Neuropathol Exp Neurol. 2003;62(9):899-907.
116. Lu DC, Zador Z, Yao J, Fazlollahi F, Manley GT. Aquaporin-4 reduces post-traumatic seizure susceptibility by promoting astrocytic glial scar formation in mice. J Neurotrauma. 2011.doi:101089/neu.2011.2114.
117. Shi WZ, Zhao CZ, Zhao B, Zheng XL, Fang SH, Lu YB, et al. Aquaporin-4 deficiency attenuates acute lesions but aggravates delayed lesions and microgliosis after cryoinjury to mouse brain. Neurosci Bull. 2012;28(1):61-8.doi:101007/s12264-012-1063-7.